Utah’s business landscape is rich with professionals who have le...Read More
Social Media and Employers: Friends or Enemies?
The Case for HSAs
Time to Show Up
Make a Move
In the Lab
Rent to Own
Back from the Dead
A Breath of Fresh Air
Travel & Tourism
Sandy—SilverVue, a rapidly-growing provider of transitional care and telehealth technologies, recently announced its acquisition of ProMD, Inc.
This strategic acquisition builds on the Company's ability to prevent patient readmissions and facilitate digital hospital discharge processes by bringing MobiMD, a mobile health technology platform created by ProMD, into the SilverVue product line.
ProMD was founded by James Barrett and Dr. Ram Nirula, Chief of Trauma at University of Utah Health Care, as a spin-out technology company through the Technology & Venture Commercialization office at the University of Utah.
Matt Evans, CEO of ProMD, led the successful development of MobiMD to facilitate communications between hospitals and their post-discharge patient populations. He now brings his industry leadership to SilverVue as Chief Strategy Officer, to continue working to improve patient outcomes and reduce readmissions with technological applications.
Dr. Nirula, a renowned trauma surgeon, is the Surgical Critical Care Fellowship Director and the Co-Director Surgical ICU Trauma Medical Director at University of Utah Hospital, and a member of the faculty at University of Utah Medical School. He will now also serve as SilverVue's Chief Medical Officer.
Will West, CEO of SilverVue, has a successful entrepreneurial history as founder of multiple Utah technology companies, including Control4, which he led to its public offering in 2013, and iBAHN, the worldwide leader in broadband services for business travelers.
West commented, "The MobiMD application harmonizes perfectly with our vision at SilverVue, and will be a strong complement to our product portfolio." He added, "We are excited to add the ProMD team to SilverVue. The acquisition continues our path of rapid growth and development, and adding the diverse industry experience and clinical expertise of Matt Evans and Ram Nirula to our executive leadership will allow us to move even faster."